EndoProMag.com

  • Home
  • News
  • Articles
  • Magazine
    • Current Issue
    • Past Issues
  • Subscribe
  • About
  • Contact
  • Home
  • News
  • Articles
  • Magazine
    • Current Issue
    • Past Issues
  • Subscribe
  • About
  • Contact
  • Home
  • News
  • Articles
  • Magazine
    • Current Issue
    • Past Issues
  • Subscribe
  • About
  • Contact
  • Home
  • News
  • Articles
  • Magazine
    • Current Issue
    • Past Issues
  • Subscribe
  • About
  • Contact
Home Irritable Bowel Syndrome

Scientists find urine test could offer a non-invasive approach for diagnosis of IBS

Scientists find urine test could offer a non-invasive approach for diagnosis of IBS
Scientists at McMaster University have identified new biomarkers for irritable bowel syndrome (IBS) in urine, which could lead to better treatments and reduce the need for costly and invasive colonoscopy procedures currently used for diagnosis. Little is known about the causes of IBS, a chronic and often debilitating gastrointestinal disorder which affects hundreds of thousands of Canadians in which diagnosis is complicated, patients experience a vast spectrum of symptoms and treatment options are limited. “Diagnostic testing for IBS involves a long process of excluding other related gut disorders, such as inflammatory bowel disease,” explained Philip Britz-McKibbin, lead author of the study and a professor in McMaster’s Department of Chemistry and Chemical Biology. “We were interested in finding if there is a better way to detect and monitor IBS that avoids invasive colonoscopy procedures while also giving us better insights into its underlying mechanisms,” he said. Researchers performed metabolite profiling studies comparing urine samples from a cohort of IBS patients with a control group of healthy adults. They discovered for the first time distinctive metabolic signatures that were elevated in the IBS patients. Several metabolites were related to collagen degradation, which researchers believe is derived from the gut, suggesting there is an impairment of the elastic lining in the colon impacting its normal function. Researchers believe the findings might also allow for routine treatment monitoring of IBS patients that can also be used to validate the efficacy of dietary and/or pharmacological interventions. Currently, they are expanding their work to discover new biomarkers in urine that can differentiate Crohn’s disease from ulcerative colitis in children, hoping they can avoid future colonoscopies altogether. This may allow for rapid screening and early detection of various chronic gut disorders more accurately and at a lower cost. Source: McMaster University

Author

  • endopromag_adn

    View all posts
Tags: News

Browse by Category

Tags

AfterCare AGA American Gastroenterological Association Anesthesiology Antibiotic Articles Bacteria cancer CellMax Chemotherapy Chloraprep colon cancer colorectal cancer COVID-19 Cybersecurity Digestive Disorders Symptoms Editor's Letter Education EndoPro All Stars Endoscope Endoscopy FDA Feature gastroenterology Gastroparesis Awareness Month GERD Getinge Healthmark Hydrotherapy IBD IBS ISO Certification Medicine MEDICINE/HEALTH Nancy Chobin News Patricia Raymond polypectomy PPE Product Locator recall SGNA Sidebar TechTalk The International Foundation for Gastrointestinal Disorders
EndoProMag.com

EndoPro Magazine is the award winning advocate for today’s endoscopy profession. We are the go-to source for endoscopy nurses, technicians, and their colleagues in hospitals, ambulatory care centers, and free-standing endoscopy facilities in the United States and abroad.

Browse by Topic

Anal CancerAntibiotic Resistance

C. diffCancerCentral Services

ColitisDiet/Body WeightEquipment

ERCPGastroenterologyView All

Current Issue

© 2025 Copyright 7 Toes Media and EndoPro Magazine. All Rights Reserved. Design & Developed by Insightful Technologies.

No Result
View All Result
  • About Us
  • Articles
  • Browse By Tags & Categories
  • Contact Us
  • Current Issue
  • Demo
  • Home
  • News
  • Past Issues
  • Subscribe

© 2025 Copyright 7 Toes Media and EndoPro Magazine. All Rights Reserved. Design & Developed by Insightful Technologies.

Go to mobile version
Verified by MonsterInsights